Redeye returns with a summary of OssDsign’s Strategy Update held at Redeye on March 2nd, as well as a brief comment on the equity issue aiming to raise SEK 240-270m. We are pleased to see that the company accelerates its efforts to reach its full potential, both with its cranial implant and the new vertical in orthobiologics.